Comparison of a new antidepressive, lofepramine, with imipramine in a double-blind multicentre trial
β Scribed by B. Woggon; J. Angst; M. Bleuler; Th. L. J. Dittmer; K. Heinrich; H. Hippius; H. Martens; I. Seibel
- Publisher
- Springer-Verlag
- Year
- 1975
- Tongue
- English
- Weight
- 335 KB
- Volume
- 221
- Category
- Article
- ISSN
- 1433-8491
No coin nor oath required. For personal study only.
β¦ Synopsis
Lofepramine, an imipramine derivative, shows lower acute toxicity in animals when compared with desipramine and imipramine. Its anticholinergic effect is less pronounced than that of desipramine. In an open clinical trial lofepramine showed a marked antidepressive action. A double-blind multicenter trial of lofepramine v. imipramine, evaluated by means of the AMP system, showed a remarkable degree of concurrence with regards to the effects of those two products.
π SIMILAR VOLUMES
Doxazosin (mean dose 11 mg) given once daily in combination with 100 mg atenolol (n = 44) was compared with placebo and atenolol (n = 43) in a double-blind, multicenter study in patients with mild to moderate essential hypertension. In the atenolol/doxazosin-treated group, standing blood pressure si
The antipanic effect and tolerability of alprazolam and imipramine were compared during 9 weeks in 55 inpatients with panic disorder with or without agoraphobia. Both drugs decreased significantly the frequency of panic attacks, alprazolam as early as 3 weeks of treatment. The symptoms of generalize